US 10617663
Dosage forms and therapeutic uses of L-4-chlorokynurenine
granted A61KA61K31/198A61K9/0053
Quick answer
US patent 10617663 (Dosage forms and therapeutic uses of L-4-chlorokynurenine) held by VISTAGEN THERAPUETICS, INC. expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VISTAGEN THERAPUETICS, INC.
- Grant date
- Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/198, A61K9/0053, A61P, A61P25/14